To determine the mechanism of CypA in NSCLC progression, LC‐MS was performed to analyze proteomic differences between the control group and the CypA knocked out NSCLC cell line by CRISPR/Cas9 gene editing. Here, PPIA is linked to non-small cell lung carcinoma.